For research use only. Not for therapeutic Use.
β-Caryophyllene-d2 (CAS: 2006272-96-2), a premium pharmaceutical research compound designed for advanced studies in anti-inflammatory and analgesic research. As a deuterated analog of β-Caryophyllene, it offers enhanced stability and improved pharmacokinetic properties. β-Caryophyllene-d2 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for pain management and inflammatory conditions. Trusted by leading laboratories, β-Caryophyllene-d2 is your go-to solution for cutting-edge anti-inflammatory research. Unlock new possibilities in pain and inflammation treatment with β-Caryophyllene-d2, where innovation meets reliability.
| Catalog Number | S000238 |
| CAS Number | 2006272-96-2 |
| Molecular Formula | C15H22D2 |
| Purity | ≥95% |
| IUPAC Name | (1R,4Z,9S)-8-(dideuteriomethylidene)-4,11,11-trimethylbicyclo[7.2.0]undec-4-ene |
| InChI | InChI=1S/C15H24/c1-11-6-5-7-12(2)13-10-15(3,4)14(13)9-8-11/h6,13-14H,2,5,7-10H2,1,3-4H3/b11-6-/t13-,14-/m1/s1/i2D2 |
| InChIKey | NPNUFJAVOOONJE-DUOVYBGSSA-N |
| SMILES | [2H]C(=C1CC/C=C(\CC[C@@H]2[C@@H]1CC2(C)C)/C)[2H] |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Cheng Y, et al. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94(1-2):1-12. [3]. Dahham SS, et al. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllenefrom the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26;20(7):11808-29. [4]. de Oliveira CC, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016 Mar;56:26-31. |
